By Cam-engaging Link Patents (Class 400/400)
  • Patent number: 8974817
    Abstract: Disclosed is a novel transdermally absorbable preparation which enables the efficient, stable and long-term administration of a drug to a living body. More specifically, the transdermally absorbable preparation comprises: a laminate comprising an outer film, a drug-containing layer and a support layer laminated in this order from the side to be contacted with the skin; and a fixing means for fixing the laminate on the skin. In the transdermally absorbable preparation, the outer film is a drug-permeable polymer film that can control the release of the drug into the skin and is provided as a surface of the laminate which is to be contact with the skin.
    Type: Grant
    Filed: March 25, 2009
    Date of Patent: March 10, 2015
    Assignee: Teikoku Seiyaku Co., Ltd.
    Inventors: Takeshi Ito, Miho Ishigure
  • Patent number: 7059789
    Abstract: A key structure. The key structure comprises a substrate, a key cover, a first rod and a resilient member disposed between the substrate and the key cover. The key cover has a receiving seat defining an opening and a receiving space. Particularly, the length of the opening is less than the receiving space, and the opening is offset with respect to the center of the receiving space. The first rod has a first end connecting the key cover and a second end connecting the substrate, wherein the first end has a protrusion passing through the opening into the receiving space.
    Type: Grant
    Filed: April 29, 2004
    Date of Patent: June 13, 2006
    Assignee: Darfon Electronics Corp.
    Inventor: Chih-Hsiang Chiang
  • Patent number: 6689382
    Abstract: The present invention provides a pharmaceutical formulation suitable for filling softgel capsules comprising: (a) a therapeutically effective amount of a non-steroidal anti-inflammatory drug selected from the group consisting of selected from the group consisting of (1) the propionic acid derivatives; (2) the acetic acid derivatives; (3) the fenamic acid derivatives; (4) the biphenylcarboxylic acid derivatives; and (5) the oxicams; as well as Cox 2 inhibitors and mixtures thereof; and (b) a solvent system comprising 40% to 60% by weight a polyoxyethylene ether of the formula: wherein n=1 to 6; 15% to 35% by weight of glycerin and 15% to 35% by weight water. In the case of compositions containing an NSAID having carboxyl function an alkaline hydroxide may be added to neutralize said hydroxide function.
    Type: Grant
    Filed: May 15, 2002
    Date of Patent: February 10, 2004
    Assignee: Procaps S.A.
    Inventors: Alfredo Berthel, Jorge Gomez